Prothena Corp Public (PRTA) Other Working Capital Changes (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Other Working Capital Changes of -$719000.0 for Q1 2026, down 11.47% year-over-year from -$812180.4 in Q1 2025, and down 1.41% quarter-over-quarter from -$709000.0 in Q4 2025.
Prothena Corp Public (PRTA) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Prothena Corp Public's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$719000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 11.47% year-over-year to -$719000.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 10.02% YoY), while the FY2025 annual figure was -$2.7 million, down 20.48% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$719000.0, down from -$709000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $50.4 million in Q4 2024, with the low at -$58.4 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$1.6 million (2023), against an average of -$3.5 million.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 77.02% in 2024, then plunged 76.71% in 2025.
- Prothena Corp Public's Other Working Capital Changes stood at -$1.6 million in 2022, then grew by 0.77% to -$1.5 million in 2023, then jumped by 57.97% to -$651000.0 in 2024, then decreased by 8.91% to -$709000.0 in 2025, then dropped by 1.41% to -$719000.0 in 2026.
- Business Quant data shows PRTA's Other Working Capital Changes at -$719000.0 in Q1 2026, -$709000.0 in Q4 2025, and -$699000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.54 Mn |
| Jun 30, 2026 | -6.54 Mn |
| Jun 30, 2026 | -6.54 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | -2.42 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Jun 30, 2025 | -8.04 Mn |
| Mar 31, 2025 | 843,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Dec 31, 2024 | 50.45 Mn |
| Dec 31, 2024 | 50.45 Mn |